1. Home
  2. EVI vs OBIO Comparison

EVI vs OBIO Comparison

Compare EVI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$15.34

Market Cap

204.6M

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$3.92

Market Cap

240.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
OBIO
Founded
1959
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
240.7M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
EVI
OBIO
Price
$15.34
$3.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$35.00
$14.25
AVG Volume (30 Days)
83.9K
535.0K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
1.81%
N/A
EPS Growth
32.43
33.13
EPS
0.31
N/A
Revenue
$389,830,000.00
$33,482,000.00
Revenue This Year
$15.53
N/A
Revenue Next Year
$3.83
$12.43
P/E Ratio
$49.55
N/A
Revenue Growth
10.26
1169.22
52 Week Low
$14.06
$2.20
52 Week High
$34.82
$5.42

Technical Indicators

Market Signals
Indicator
EVI
OBIO
Relative Strength Index (RSI) 43.66 45.34
Support Level $14.06 $3.47
Resistance Level $21.36 $4.18
Average True Range (ATR) 0.92 0.28
MACD 0.14 -0.03
Stochastic Oscillator 43.90 12.53

Price Performance

Historical Comparison
EVI
OBIO

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: